Researchers have identified microRNA-93 as a key genetic driver of fatty liver disease and discovered that vitamin B3 can effectively shut it down. This finding suggests a safe, widely available ...

A new study suggests Vitamin B3 may help reverse fatty liver disease by targeting microRNA-93, which drives fat buildup. By ...

Researchers have discovered that a tiny molecule, known as microRNA-93 (miR-93), is the primary driver of fatty liver disease ...

A surprising new study reveals that blocking a supposedly protective enzyme, Caspase-2, could actually backfire—raising the risk of chronic liver damage and cancer over time. Researchers found that ...

Obesity worsens chronic liver disease, but novel medications and bariatric surgery offer new options. Learn more about effective weight-loss strategies.

Metabolic dysfunction-associated steatotic liver disease (MASLD) can cause more serious liver conditions, such as liver failure. A new study, led by Lund University in Sweden, presents new data that ...

When most people think about liver disease, they think about alcohol or hepatitis. What many don’t realize is that the most ...

Previously known as non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease is common in older adults. As people age, they often experience increased ...

Learn how beta-blockers, including carvedilol, can be used in advanced liver disease to manage portal hypertension and reduce first decompensation risk.

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects nearly one in three adults around the globe. It starts when fat builds up inside the liver’s cells. Over time, this buildup can ...

Altimmune, Inc. (NASDAQ:ALT) earns a spot on our list of the top 10 stocks under $5 that could triple. On March 16, 2026, H.C ...